Exelixis Inc., a luminary biopharmaceutical company, has been making waves in the oncology sector with its innovative cancer treatments. The company’s commitment to developing breakthrough therapies is not only revolutionizing cancer care but also positioning it for a promising future. At the heart of Exelixis’s success is cabozantinib, a versatile cancer treatment with promising applications […]